WAVES
WAVES are up $5000.00 ++++
Friday's newsletter Alert
AXCG, SFAZ
View this email in your browser
TSUNAMI WAVES
AXCG .000
SAFZ .01
PHIL 1.85
AMBS .15
OGNG .215
SPMI .179
It has been a great end of the year as well and here are the Waves since September updated to today's cost.
AMBS I am totally free in now and have several other on the way. AMBS called at .0045 and AXCG called at .0006.
Goal this year is 75% up 250% and 50% up 500% or better with only 15% down the end of the year.
Follow the waves as they move up all year. Below is the percent and cash grown since September start.
Dave
Symbol Qty Purchase Price Day Gain(%) Last Gain($) Gain(%) Mkt Val
AMBS 10000 0.0001 0.60 0.1506 1,505.00 150,500.00 1,506.00
OGNG 5000 0.03 0.00 0.215 925.00 616.67 1,075.00
SFAZ 750000 0.0025 0.00 0.0095 5,250.00 280.00 7,125.00
AXCG 1500000 0.0004 0.00 0.0008 600.00 100.00 ]1,200.00
PHIL 3000 1.09 0.00 1.85 2,280.00 69.72 5,550.00
FEGR 200000 0.0003 0.00 0.0004 20.00 33.33 80.00
SPMI 25000 0.015 2.23 0.0179 72.50 19.33 447.50 [/color]
EXPU 100000 0.0012 0.00 0.0012 0.00 0.00 120.00
SANT 10000 0.005 0.00 0.005 0.00 0.00 50.00
VSPC 10000 0.0138 0.00 0.012 -18.00 -13.04 120.00
FEGRD 50000 0.006 0.00 0.0049 -55.00 -18.33 245.00
SANTD 250 2.00 -- -- -- -- --
make sure you sign up for thecoffeewave/com newsletters for the real winners for the year.
SFAZ .0085 & AXCG .0009 Triple trips Friday Tsunami Alerts
for two breaking the one spots and one starting this week.
3 charts below.
Follow us to the best long term board on IHUB
$THE WAVE (WAVERIDER$)
thewaveinvestors
Scroll down for more posts ▼
Top 10 Most Recent News Articles
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...
Continue Reading
Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...
Continue Reading
Top 5 Most Recently Viewed Articles
Carrier's Generous Pledge for Wildfire Relief In a significant initiative aimed at supporting communities affected by wildfires, Carrier Global Corporation (NYSE: CARR), a leader in intelligent climate solutions, has announced its commitment to donate over $2.5 million worth of indoor air purifiers. This effort is specifically directed towards enhancing air quality for...
Continue Reading
Lundbeck Reveals Insights into Multiple System Atrophy at International Congress VALBY, Denmark – H. Lundbeck A/S (Lundbeck) is set to present pivotal pipeline data and invaluable patient perspectives from the recent AMULET trial, highlighting amlenetug as a promising treatment for the rare neurological disorder known as multiple system atrophy (MSA). This significant...
Continue Reading
Welcome to Keenova Therapeutics In an exciting announcement, Mallinckrodt plc has successfully completed the planned spin-off of its Par Health generic pharmaceuticals and sterile injectables businesses. As of now, the company will operate under the new name, Keenova Therapeutics, dedicating its efforts towards developing and delivering innovative therapies for patients...
Continue Reading
Recent Financial Developments at Ageas In an important disclosure regarding financial transparency, BlackRock, Inc. has officially notified Ageas that it has exceeded the legal threshold of 5% ownership in the company, with its current shareholding reaching an impressive 7.78%. This notification was made in accordance with regulatory requirements aimed at maintaining...
Continue Reading
Decline in Revenue for AKWEL in Recent Financial Update AKWEL, a key player in the automotive and heavy-vehicle parts market, has announced a notable decline in their financial performance for the first nine months of the year. The company, specializing in fluid management and structural parts for electric vehicles, has reported a consolidated revenue of €757.7 million,...
Continue Reading